Form 4: Health Catalyst Insider Sells Shares for Tax Withholding

Health Catalyst CEO Albert Benjamin reported a transaction involving the sale of 34,485 shares to cover tax withholding obligations upon the vesting of restricted stock units.

Summary

• Albert Benjamin, CEO and Director of Health Catalyst, Inc. (HCAT), reported a transaction on June 10, 2026.
• The transaction involved the sale of 34,485 shares of common stock.
• The sale was executed at a price of $1.6918 per share.
• This sale was to cover tax withholding obligations related to the vesting of restricted stock units.
• The company's equity incentive plans mandate this 'sell to cover' transaction.
• Following this transaction, Benjamin beneficially owns 1,423,971 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard procedure for covering tax obligations upon equity vesting and not indicative of a change in the insider's conviction about the company's prospects.

Negatives

• Insider selling, even for tax purposes, can sometimes be perceived negatively by the market.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

• The sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholding upon vesting of equity awards, are common in the technology and healthcare sectors as compensation structures often involve stock-based incentives.

Stakeholder Impact

• Shareholders: The sale is a routine event for tax purposes and does not directly impact the company's operational performance or strategic direction. However, any insider selling can be a point of observation for investors.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO, Director